Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Schizophrenia is a devastating neurodevelopmental disorder whose genetic influences remain elusive. We hypothesize that individually rare structural variants contribute to the illness. Microdeletions and microduplications >100 kilobases were identified by microarray comparative genomic hybridization of genomic DNA from 150 individuals with schizophrenia and 268 ancestry-matched controls. All variants were validated by high-resolution platforms. Novel deletions and duplications of genes were present in 5% of controls versus 15% of cases and 20% of young-onset cases, both highly significant differences. The association was independently replicated in patients with childhood-onset schizophrenia as compared with their parents. Mutations in cases disrupted genes disproportionately from signaling networks controlling neurodevelopment, including neuregulin and glutamate pathways. These results suggest that multiple, individually rare mutations altering genes in neurodevelopmental pathways contribute to schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, a rare CNV for ERBB4 has been identified in schizophrenia46.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [46]
In the citing paper
“In addition, rare but highly penetrant CNVs have been found in many genes encoding synaptic proteins46.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [46]
In the citing paper
“Early findings from our group observed a 3-fold enrichment of rare genic CNVs in cases as compared with controls (Walsh et al., 2008).”
From CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics (2012) · cites this paper as Walsh et al., 2008
In the citing paper
“Early on, it was apparent that rare CNVs tended to impact genes involved in neuronal function (Walsh et al., 2008). These included functional categories related to synaptic activity and neurodevelopment (Malhotra et al., 2011; Walsh et al., 2008).”
From CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics (2012) · cites this paper as Walsh et al., 2008
In the citing paper
“While the strength of evidence supporting specific pathways differs between data sets, we do find evidence consistent with our earlier observations that there is an enrichment of “neurodevelopmental” and “synaptic” genes among rare CNVs in SCZ (Walsh et al., 2008).”
From High frequencies of de novo CNVs in bipolar disorder and schizophrenia (2011) · cites this paper as Walsh et al., 2008
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Detection of large-scale variation in the human genome
Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W., & Lee, C. (2004) · Nature Genetics · doi:10.1038/ng1416 · Cited by 2,892
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Self-citationSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Association between Microdeletion and Microduplication at 16p11.2 and Autism
Weiss, L. A., Shen, Y., Korn, J. M., Arking, D. E., Miller, D. T., Fossdal, R., Saemundsen, E., Stefansson, H., Ferreira, M. A. R., Green, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075974 · Cited by 1,666
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
The Autism Genome Project Consortium (2007) · Nature Genetics · doi:10.1038/ng1985 · Cited by 1,402
Segmental Duplications and Copy-Number Variation in the Human Genome
Sharp, A. J., Locke, D. P., McGrath, S. D., Cheng, Z., Bailey, J. A., Vallente, R. U., Pertz, L. M., Clark, R. A., Schwartz, S., Segraves, R., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/431652 · Cited by 972
Self-citationRecurrent 16p11.2 microdeletions in autism
Kumar, R. A., KaraMohamed, S., Sudi, J., Conrad, D. F., Brune, C., Badner, J. A., Gilliam, T. C., Nowak, N. J., Cook, E. H., Dobyns, W. B., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm376 · Cited by 731
Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes
Lupski, J. R., & Stankiewicz, P. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010049 · Cited by 582
The DISC locus in psychiatric illness
Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J., & Millar, J. K. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002106 · Cited by 542
Research works printed but not linked: 4
- G. Kirovet al., Hum. Mol. Genet.17, 458 (2008).
- National Center for Biotechnology Information National Library of Medicine Bethesda MD www.ncbi.nlm.nih.gov.
- K. M. Giehl, Prog. Exp. Tumor Res.39, 1 (2007).
- N. Nortonet al., Am. J. Med. Genet. B Neuropsychiatr. Genet.141, 96 (2006).
Cited by
Items 201–300 of 1,001
Abnormal structure or function of the amygdala is a common component of neurodevelopmental disorders
Schumann, C. M., Bauman, M. D., & Amaral, D. G. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2010.09.028 · Cited by 178
“In addition to genetic risk (Walsh et al., 2008), obstetric events (Clarke, Harley, & Cannon, 2006) such as maternal malnourishment (Susser et al., 1996), stress (Huttunen & Niskanen, 1978), or infection (Davies, Welham, Chant, Torrey, & McGrath, 2003) in utero, may be contributory factors to…”
BackgroundKendler, K. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.50 · Cited by 178
Recent advances in the molecular genetics of epilepsy
Hildebrand, M. S., Dahl, H. M., Damiano, J. A., Smith, R. J. H., Scheffer, I. E., & Berkovic, S. F. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101448 · Cited by 178
Licinio, J., Dong, C., & Wong, M.-L. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.38 · Cited by 176
Tomescu, M. I., Rihs, T. A., Becker, R., Britz, J., Custo, A., Grouiller, F., Schneider, M., Debbané, M., Eliez, S., & Michel, C. M. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.036 · Cited by 176
Griswold, A. J., Ma, D., Cukier, H. N., Nations, L. D., Schmidt, M. A., Chung, R.-H., Jaworski, J. M., Salyakina, D., Konidari, I., Whitehead, P. L., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds164 · Cited by 175
Autism spectrum disorder in the genetics clinic: a review
Carter, M., & Scherer, S. (2013) · Clinical Genetics · doi:10.1111/cge.12101 · Cited by 174
Childhood-Onset Schizophrenia and Early-onset Schizophrenia Spectrum Disorders
Driver, D. I., Thomas, S., Gogtay, N., & Rapoport, J. L. (2019) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2019.08.017 · Cited by 174
Self-citationThe neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits
Buonanno, A. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.07.012 · Cited by 173
Carlisle, H. J., Fink, A. E., Grant, S. G. N., & O’Dell, T. J. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.163469 · Cited by 172
“Moreover, mutations in genes encoding SAP102 and PSD-93 have recently been identified in X-linked mental retardation (Tarpey et al. 2004) and schizophrenia (Walsh et al. 2008), respectively.”
BackgroundKim, I. H., Racz, B., Wang, H., Burianek, L., Weinberg, R., Yasuda, R., Wetsel, W. C., & Soderling, S. H. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.0035-13.2013 · Cited by 172
“Genomic studies of risk factors has led to a developing consensus that these disorders may reflect a signaling network or “pathway” dysfunction (Walsh et al., 2008; International Schizophrenia Consortium et al., 2009; Gilman et al., 2011; Sakai et al., 2011; Voineagu et al., 2011; Casey et al.,…”
BackgroundJoint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia
Bergen, S. E., Ploner, A., Howrigan, D., CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium, O’Donovan, M. C., Smoller, J. W., Sullivan, P. F., Sebat, J., Neale, B., & Kendler, K. S. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17040467 · Cited by 171
Self-citationSchizophrenia shows a unique metabolomics signature in plasma
He, Y., Yu, Z., Giegling, I., Xie, L., Hartmann, A. M., Prehn, C., Adamski, J., Kahn, R., Li, Y., Illig, T., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.76 · Cited by 171
Genetics of restless legs syndrome
Winkelmann, J. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0033-y · Cited by 170
Gene–environment interplay in the etiology of psychosis
Zwicker, A., Denovan‐Wright, E. M., & Uher, R. (2018) · Psychological Medicine · doi:10.1017/s003329171700383x · Cited by 171
“Psychosis-associated rare variants, including deletions/ duplications and copy number variants, are more prevalent in genes involved in neurodevelopment, e.g. neuregulin (Walsh et al. 2008).”
BackgroundRosenfeld, J. A., Ballif, B. C., Torchia, B. S., Sahoo, T., Ravnan, J. B., Schultz, R., Lamb, A., Bejjani, B. A., & Shaffer, L. G. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181f0c5f3 · Cited by 169
Childhood Onset Schizophrenia and Early Onset Schizophrenia Spectrum Disorders
Driver, D. I., Gogtay, N., & Rapoport, J. L. (2013) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2013.04.001 · Cited by 169
Self-citationMikhail, F. M., Lose, E. J., Robin, N. H., Descartes, M. D., Rutledge, K. D., Rutledge, S. L., Korf, B. R., & Carroll, A. J. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34177 · Cited by 168
Translating Glutamate: From Pathophysiology to Treatment
Javitt, D. C., Schoepp, D., Kalivas, P. W., Volkow, N. D., Zarate, C., Merchant, K., Bear, M. F., Umbricht, D., Hajos, M., Potter, W. Z., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002804 · Cited by 168
“Glutamate- and nonglutamate-related genes implicated in schizophrenia: meta-analysis and genome-wide association studies (8, 153, 154).”
BackgroundThe complement control-related genes CSMD1 and CSMD2 associate to schizophrenia
Håvik, B., Le Hellard, S., Rietschel, M., Lybæk, H., Djurovic, S., Mattheisen, M., Mühleisen, T. W., Degenhardt, F., Priebe, L., Maier, W., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.030 · Cited by 168
Contact in the genetics of autism and schizophrenia
Burbach, J. P. H., & van der Zwaag, B. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.002 · Cited by 168
Lesch, K.-P., Selch, S., Renner, T. J., Jacob, C., Nguyen, T. T., Hahn, T., Romanos, M., Walitza, S., Shoichet, S., Dempfle, A., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.29 · Cited by 167
Human uniqueness: genome interactions with environment, behaviour and culture
Varki, A., Geschwind, D. H., & Eichler, E. E. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2428 · Cited by 167
Self-citationSynaptic proteins and receptors defects in autism spectrum disorders
Chen, J., Yu, S., Fu, Y., & Li, X. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00276 · Cited by 167
Disruptive insights in psychiatry: transforming a clinical discipline
Insel, T. R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38832 · Cited by 167
TARPs differentially decorate AMPA receptors to specify neuropharmacology
Kato, A., Gill, M. B., Yu, H. Y., Nisenbaum, E. S., & Bredt, D. S. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.02.004 · Cited by 167
Psychedelics and schizophrenia
González-Maeso, J., & Sealfon, S. C. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.005 · Cited by 166
Genetics of bipolar disorder: successful start to a long journey
Craddock, N., & Sklar, P. (2009) · Trends in Genetics · doi:10.1016/j.tig.2008.12.002 · Cited by 166
Genetics of autism spectrum disorders
Kumar, R. A., & Christian, S. L. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0029-2 · Cited by 166
“The duplication also has been observed in patients with schizophrenia [ 40 ] and bipolar disorder [37].”
BackgroundGlutamate signaling in the pathophysiology and therapy of schizophrenia
Lin, C., Lane, H., & Tsai, G. E. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.023 · Cited by 168
“Various lines of evidence, including susceptibility genes (Jaaro-Peled et al., 2009; Shi et al., 2008; Walsh et al., 2008), environmental risk”
Xu, B., Woodroffe, A., Rodriguez-Murillo, L., Roos, J. L., van Rensburg, E. J., Abecasis, G. R., Gogos, J. A., & Karayiorgou, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908584106 · Cited by 156
“Nevertheless, essentially identical enrichment (relative enrichment 1.85, 27% vs. 14.5%, Fisher’s Exact Test P 0.05) was obtained upon further filtering that removed rare inherited variants overlapping with DGV (hg18 version 4).”
BackgroundInfluentialKarlsson, R.-M., Tanaka, K., Saksida, L. M., Bussey, T. J., Heilig, M., & Holmes, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.215 · Cited by 165
“An association study found no polymorphism in the gene encoding human GLAST (SLC1A3) in a Japanese population with schizophrenia (Deng et al, 2007) however a more recent study found increased incidence of a rare genetic variant in the human gene encoding GLAST in schizophrenics (Walsh et al, 2008).”
What We Know: Findings That Every Theory of Schizophrenia Should Explain
MacDonald, A. W., & Schulz, S. C. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp017 · Cited by 165
Cherlyn, S. Y. T., Woon, P. S., Liu, J. J., Ong, W. Y., Tsai, G. C., & Sim, K. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.002 · Cited by 165
Xie, L., Evangelidis, T., Xie, L., & Bourne, P. E. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002037 · Cited by 165
The genetics of neurodevelopmental disease
Mitchell, K. J. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.08.009 · Cited by 164
Next-Generation Treatments for Mental Disorders
Insel, T. R. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004873 · Cited by 164
A New Testing Strategy to Identify Rare Variants with Either Risk or Protective Effect on Disease
Ionita-Laza, I., Buxbaum, J. D., Laird, N. M., & Lange, C. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001289 · Cited by 147
Structure-based systems biology for analyzing off-target binding
Xie, L., Xie, L., & Bourne, P. E. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.01.004 · Cited by 163
“From a causal perspective, multiple node failures have been called “fail-on” [3], and used to explain neurological disorders [5] and cancer [6,7] in recent genome-wide studies.”
BackgroundGenetics of Congenital Anomalies of the Kidney and Urinary Tract: The Current State of Play
Capone, V. P., Morello, W., Taroni, F., & Montini, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040796 · Cited by 164
“Copy number variations (CNVs), defined as gain or loss of germ line DNA of a size ranging from 1 kilobase (Kb) to several megabases (Mb) [54] (identified by array-based Comparative Genomic Hybridization (aCGH) and high-density SNP arrays), are a common feature of the human genome [55,56] and have been associated with…”
BackgroundCopy number variations and risk for schizophrenia in 22q11.2 deletion syndrome
Bassett, A. S., Marshall, C. R., Lionel, A. C., Chow, E. W. C., & Scherer, S. W. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn307 · Cited by 162
Abel, H. J., & Duncavage, E. J. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.11.002 · Cited by 162
Identification of blood biomarkers for psychosis using convergent functional genomics
Kurian, S. M., Le-Niculescu, H., Patel, S. D., Bertram, D., Davis, J., Dike, C., Yehyawi, N., Lysaker, P., Dustin, J., Caligiuri, M., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.117 · Cited by 162
The Human Language–Associated Gene SRPX2 Regulates Synapse Formation and Vocalization in Mice
Sia, G. M., Clem, R. L., & Huganir, R. L. (2013) · Science · doi:10.1126/science.1245079 · Cited by 147
Lenroot, R. K., & Giedd, J. N. (2008) · Development and Psychopathology · doi:10.1017/s0954579408000552 · Cited by 143
“…has shown that a particular clinical syndrome may be associated with a wide variety of genetic risk factors, suggesting that there may be multiple routes from nucleotide to behavior (Abrahams & Geschwind, 2008; Owen, Craddock, & O’Donovan, 2005; Samaco, Hogart, & LaSalle, 2005; Walsh et al., 2008).”
BackgroundExpanding the range of ZNF804A variants conferring risk of psychosis
Steinberg, S., Mors, O., Børglum, A. D., Gustafsson, O., Werge, T., Mortensen, P. B., Andreassen, O. A., Sigurdsson, E., Thorgeirsson, T. E., Böttcher, Y., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.149 · Cited by 161
Ricard, G., Molina, J., Chrast, J., Gu, W., Gheldof, N., Pradervand, S., Schütz, F., Young, J. I., Lupski, J. R., Reymond, A., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000543 · Cited by 148
Zebrafish Models of Neurodevelopmental Disorders: Past, Present, and Future
Sakai, C., Ijaz, S., & Hoffman, E. J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00294 · Cited by 160
“The genetics of schizophrenia are complex, with over 100 common variants identified by genome-wide association studies (GWAS; Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014), and rare damaging variants and CNVs contributing to risk according to a polygenic model (Walsh et al., 2008; Purcell e…”
BackgroundNMDAR Hypofunction Animal Models of Schizophrenia
Lee, G., & Zhou, Y. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00185 · Cited by 160
“Both clinical and basic research suggest that schizophrenia is a neurodevelopmental disorder involving a variety of susceptibility genes, environmental risk factors, and epigenetic alterations (Cardno et al., 1999; Cannon et al., 2002; Shi et al., 2008; Walsh et al., 2008; Jaaro-Peled et al., 2009; Singh and O’Reilly,…”
BackgroundGene-Network Analysis Identifies Susceptibility Genes Related to Glycobiology in Autism
van der Zwaag, B., Franke, L., Poot, M., Hochstenbach, R., Spierenburg, H. A., Vorstman, J. A. S., van Daalen, E., de Jonge, M. V., Verbeek, N. E., Brilstra, E. H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005324 · Cited by 145
Khoury, M. J., Bertram, L., Boffetta, P., Butterworth, A. S., Chanock, S. J., Dolan, S. M., Fortier, I., Garcia-Closas, M., Gwinn, M., Higgins, J. P. T., et al. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp119 · Cited by 146
“Such variants were not assessed in the first wave of GWAS, but they are being increasingly targeted in current and future efforts (44, 45).”
BackgroundUse of race, ethnicity, and ancestry data in health research
Lu, C., Ahmed, R., Lamri, A., & Anand, S. S. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001060 · Cited by 158
Ernst, C., Mechawar, N., & Turecki, G. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.09.001 · Cited by 158
Xu, D., Shen, W., Guo, R., Xue, Y., Peng, W., Sima, J., Yang, J., Sharov, A. A., Srikantan, S., Yang, J., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3479 · Cited by 158
Mapping Rare and Common Causal Alleles for Complex Human Diseases
Raychaudhuri, S. (2011) · Cell · doi:10.1016/j.cell.2011.09.011 · Cited by 131
Lin, G. N., Corominas, R., Lemmens, I., Yang, X., Tavernier, J., Hill, D. E., Vidal, M., Sebat, J., & Iakoucheva, L. M. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.010 · Cited by 155
“…Pinto et al., 2010; Sanders et al., 2011; Sebat et al., 2007), schizophrenia (SCZ) (Consortium, 2008; Kirov et al., 2009; Stefansson et al., 2008; Walsh et al., 2008), bipolar disorder (BD) (Malhotra et al., 2011), developmental delay (DD) (Cooper et al., 2011), attention deficit hyperactivity…”
BackgroundSelf-citationEdelmann, L. J., & Hirschhorn, K. (2008) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03610.x · Cited by 154
Aston, K. I., & Carrell, D. T. (2009) · Journal of Andrology · doi:10.2164/jandrol.109.007971 · Cited by 152
“…genome-wide association studies is an increased incidence of large structural variations associated with schizophrenia (Stefansson et al, 2008; Walsh et al, 2008), as well as Li-Fraumeni cancer predisposition syndrome (Shlien et al, 2008), a possible indication of overall increased genomic…”
BackgroundEmerging links between homeostatic synaptic plasticity and neurological disease
Wondolowski, J., & Dickman, D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00223 · Cited by 132
“Hence, a core postsynaptic step in homeostatic signaling, control of local protein synthesis, may contribute to retrograde signaling and the synaptic dysfunction contributing to these diseases.”
BackgroundDrew, L. J., Crabtree, G. W., Markx, S., Stark, K. L., Chaverneff, F., Xu, B., Mukai, J., Fenelon, K., Hsu, P., Gogos, J. A., et al. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.09.007 · Cited by 137
Sun, C., Cheng, M.-C., Qin, R., Liao, D.-L., Chen, T.-T., Koong, F.-J., Chen, G., & Chen, C.-H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr208 · Cited by 130
What is complex about complex disorders?
Mitchell, K. J. (2012) · Genome Biology · doi:10.1186/gb-2012-13-1-237 · Cited by 115
Bundy, H., Stahl, D., & MacCabe, J. H. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01623.x · Cited by 150
“Recently, copy number variations (CNVs) have emerged as risk factors for schizophrenia (28, 29), particularly rare de novo mutations (30, 31).”
BackgroundCahan, P., Li, Y., Izumi, M., & Graubert, T. A. (2009) · Nature Genetics · doi:10.1038/ng.350 · Cited by 133
“However, the role of copy number variation in mediating both 'normal' phenotypic variation and disease susceptibility is only beginning to emerg”
BackgroundAskland, K. D., Read, C., & Moore, J. H. (2008) · Human Genetics · doi:10.1007/s00439-008-0600-y · Cited by 150
The genetic variability and commonality of neurodevelopmental disease
Coe, B. P., Girirajan, S., & Eichler, E. E. (2012) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31327 · Cited by 124
Self-citationWang, D. D., & Kriegstein, A. R. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhq124 · Cited by 148
Singleton deletions throughout the genome increase risk of bipolar disorder
Zhang, D., Cheng, L., Qian, Y., Alliey-Rodriguez, N., Kelsoe, J. R., Greenwood, T., Nievergelt, C., Barrett, T. B., McKinney, R., Schork, N., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.144 · Cited by 148
Costain, G., Lionel, A. C., Merico, D., Forsythe, P., Russell, K., Lowther, C., Yuen, T., Husted, J., Stavropoulos, D. J., Speevak, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt297 · Cited by 134
“3 6505 181 46 843 667 16 998 Loss † Candidate gene, selected based on the reported neuropsychiatric/neurodevelopmental phenotype identified from systematic searches of human (e.g. Online Mendelian Inheritance in Man; http://www.omim.org/) and model organism (e.g. Mouse Genome Informatics; http://www.informatics.jax.or…”
BackgroundResultInfluentialChildhood onset schizophrenia: support for a progressive neurodevelopmental disorder
Rapoport, J. L., & Gogtay, N. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.10.003 · Cited by 132
“be increased for our COS population (Walsh et al., 2008), only two variants (16p11.”
BackgroundInfluentialSelf-citationInhibitory engrams in perception and memory
Barron, H. C., Vogels, T. P., Behrens, T. E., & Ramaswami, M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701812114 · Cited by 147
Law, A. J., Wang, Y., Sei, Y., O’Donnell, P., Piantadosi, P., Papaleo, F., Straub, R. E., Huang, W., Thomas, C. J., Vakkalanka, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206118109 · Cited by 147
“0) was used to calculate haplotype frequencies and to assign diplotypes to individuals (8).”
MethodAssociation Analysis of 94 Candidate Genes and Schizophrenia-Related Endophenotypes
Greenwood, T. A., Light, G. A., Swerdlow, N. R., Radant, A. D., & Braff, D. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029630 · Cited by 134
Timms, A. E., Dorschner, M. O., Wechsler, J., Choi, K. Y., Kirkwood, R., Girirajan, S., Baker, C., Eichler, E. E., Korvatska, O., Roche, K. W., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1195 · Cited by 134
“Further, no previously reported pathogenic large rare CNVs were identified.(7,24) Therefore, we conclude that rare CNVs are not responsible for schizophrenia in these families.”
BackgroundSelf-citationArrode-Brusés, G., & Brusés, J. L. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-83 · Cited by 146
“However, epidemiological and genetic studies suggest that the interaction between genetic abnormalities and epigenetic factors perturb the formation of the central nervous system (CNS), resulting in the cognitive, sensorial and emotional dysfunctions observed in mental illness [1-5].”
Modeling cognitive endophenotypes of schizophrenia in mice
Kellendonk, C., Simpson, E. H., & Kandel, E. R. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.02.003 · Cited by 138
Copy-number variants in neurodevelopmental disorders: promises and challenges
Merikangas, A. K., Corvin, A. P., & Gallagher, L. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.10.006 · Cited by 145
Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes
1q21.1 Study Group, Rosenfeld, J. A., Traylor, R. N., Schaefer, G. B., McPherson, E. W., Ballif, B. C., Klopocki, E., Mundlos, S., Shaffer, L. G., & Aylsworth, A. S. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.6 · Cited by 143
Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss
Bennett, M. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.003 · Cited by 144
Characteristics of de novo structural changes in the human genome
Kloosterman, W. P., Francioli, L. C., Hormozdiari, F., Marschall, T., Hehir-Kwa, J. Y., Abdellaoui, A., Lameijer, E.-W., Moed, M. H., Koval, V., Renkens, I., et al. (2015) · Genome Research · doi:10.1101/gr.185041.114 · Cited by 126
“2007), schizophrenia (Walsh et al. 2008), and intellectual disability (Cooper et al.”
Self-citationIMGSAC, Maestrini, E., Pagnamenta, A. T., Lamb, J. A., Bacchelli, E., Sykes, N. H., Sousa, I., Toma, C., Barnby, G., Butler, H., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.34 · Cited by 143
Naaijen, J., Bralten, J., Poelmans, G., The IMAGE consortium, Faraone, S., Asherson, P., Banaschewski, T., Buitelaar, J., Franke, B., P Ebstein, R., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.273 · Cited by 142
“43 In addition, top fi ndings within genome-wide association studies of psychiatric disorders have been found to converge on common underlying biological processes, suggesting that multiple genetic variants within interacting sets of genes are involved in the etiology of psychiatric disorders.”
BackgroundTanda, K., Nishi, A., Matsuo, N., Nakanishi, K., Yamasaki, N., Sugimoto, T., Toyama, K., Takao, K., & Miyakawa, T. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-19 · Cited by 134
“Among the several pathways and processes overrepresented by disrupted genes in schizophrenia cases, NO signaling pathways were the most statistically reliable [31].”
BackgroundInfluentialPast, present and future directions in human genetic susceptibility to tuberculosis
Möller, M., de Wit, E., & Hoal, E. G. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00600.x · Cited by 141
SNP-based pathway enrichment analysis for genome-wide association studies
Weng, L., Macciardi, F., Subramanian, A., Guffanti, G., Potkin, S. G., Yu, Z., & Xie, X. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-99 · Cited by 123
“Besides, axon guidance pathway, long-term depression pathway and long-term potentiation pathway were reported in a recent study where pathways were overrepresented by genes disrupted by copy number variants in schizophrenia cases [36].”
BackgroundEtherton, M. R., Tabuchi, K., Sharma, M., Ko, J., & Südhof, T. C. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.182 · Cited by 140
High-resolution copy number variation analysis of schizophrenia in Japan
Kushima, I., Aleksić, B., Nakatochi, M., Shimamura, T., Shiino, T., Yoshimi, A., Kimura, H., Takasaki, Y., Wang, C., Xing, J., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.88 · Cited by 140
Confirmed rare copy number variants implicate novel genes in schizophrenia
Tam, G. W. C., van de Lagemaat, L. N., Redon, R., Strathdee, K. E., Croning, M. D. R., Malloy, M. P., Muir, W. J., Pickard, B. S., Deary, I. J., Blackwood, D. H. R., et al. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380445 · Cited by 139
Pagnamenta, A. T., Bacchelli, E., de Jonge, M. V., Mirza, G., Scerri, T. S., Minopoli, F., Chiocchetti, A., Ludwig, K. U., Hoffmann, P., Paracchini, S., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.02.002 · Cited by 139
Gene copy number variation and common human disease
Fanciulli, M., Petretto, E. G., & Aitman, T. J. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01342.x · Cited by 140
“found novel deletions and duplications in 15% of cases and in 20% of youngonset cases, compared to 5% of controls (90), with similar results reported by others (91, 93).”
BackgroundResultVisscher, P. M., Goddard, M. E., Derks, E. M., & Wray, N. R. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.65 · Cited by 138
Development of Patient-Specific Neurons in Schizophrenia Using Induced Pluripotent Stem Cells
Pedrosa, E., Sandler, V., Shah, A., Carroll, R., Chang, C., Rockowitz, S., Guo, X., Zheng, D., & Lachman, H. M. (2011) · Journal of Neurogenetics · doi:10.3109/01677063.2011.597908 · Cited by 129
“…are widely viewed as neurodevelopmental in origin (Fatemi & Folsom, 2009; Geschwind & Levitt, 2007; Gratacos et al., 2008; Guilmatre et al., 2009; Walsh et al., 2008; Weinberger, 1997), and consequently, analyzing brain tissue decades removed from primary etiological events may not address…”
BackgroundSchizophrenia Gene Networks and Pathways and Their Applications for Novel Candidate Gene Selection
Sun, J., Jia, P., Fanous, A. H., van den Oord, E., Chen, X., Riley, B. P., Amdur, R. L., Kendler, K. S., & Zhao, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011351 · Cited by 124
High rate of disease-related copy number variations in childhood onset schizophrenia
Ahn, K., Gotay, N., Andersen, T. M., Anvari, A. A., Gochman, P., Lee, Y., Sanders, S., Guha, S., Darvasi, A., Glessner, J. T., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.59 · Cited by 132
“As shown in Table 2, we identified five COS probands who carried CNVs previously reported only for ID (4) or autism (1); however, three of these represented ‘second hits’ for previously identified probands carrying schizophrenia-associated CNVs.”
BackgroundSelf-citationHolloway, T., Moreno, J. L., Umali, A., Rayannavar, V., Hodes, G. E., Russo, S. J., & González-Maeso, J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2331-12.2013 · Cited by 123
“There is extensive evidence to suggest that genetics plays a significant role in the etiology of schizophrenia (International Schizophrenia Consortium et al., 2008; Stefansson et al., 2008, 2009; Walsh et al., 2008; Purcell et al., 2009).”
BackgroundAssociation screening of common and rare genetic variants by penalized regression
Zhou, H., Sehl, M. E., Sinsheimer, J. S., & Lange, K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq448 · Cited by 137
“The CDRV hypothesis receives support from traits such as low plasma levels of HDL cholesterol (Cohen et al., 2004), cystic fibrosis (Dean and Santis, 1994), colorectal adenomas (Azzopardi et al., 2008), familial breast cancer (Johnson et al., 2007) and schizophrenia (Walsh et al., 2008).”
BackgroundLong Non-Coding RNA (lncRNA) Roles in Cell Biology, Neurodevelopment and Neurological Disorders
Aliperti, V., Skonieczna, J., & Cerase, A. (2021) · Non-Coding RNA · doi:10.3390/ncrna7020036 · Cited by 137
Genomic Copy Number Variation in Disorders of Cognitive Development
Morrow, E. M. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.08.009 · Cited by 121
The role of glutamate and glutamine metabolism and related transporters in nerve cells
Zhang, D., Hua, Z., & Li, Z. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14617 · Cited by 138
“32 GLAST is expressed in the first 2 weeks after birth, and GLT-1 is expressed in the first 10–15 days after birth.”
BackgroundGenome-Wide Scan of Copy Number Variation in Late-Onset Alzheimer's Disease
Heinzen, E. L., Need, A. C., Hayden, K. M., Chiba-Falek, O., Roses, A. D., Strittmatter, W. J., Burke, J. R., Hulette, C. M., Welsh-Bohmer, K. A., & Goldstein, D. B. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1212 · Cited by 131
“As several neuropsychiatric diseases have been shown to share common risk loci [20,24,25,31,37], we then screened all previously reported neuropsychiatric risk regions for rare CNVs enriched in AD cases (see Materials and Methods for a list of regions evaluated).”
Background
Metadata
- Authors
- Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., Stray, S. M., Rippey, C. F., Roccanova, P., Makarov, V., Lakshmi, B., Findling, R. L., Sikich, L., Stromberg, T., Merriman, B., Gogtay, N., Butler, P., Eckstrand, K., Noory, L., Gochman, P., Long, R., Chen, Z., Davis, S., Baker, C., Eichler, E. E., Meltzer, P. S., Nelson, S. F., Singleton, A. B., Lee, M. K., Rapoport, J. L., King, M.-C., & Sebat, J.
- Affiliations
- National Institutes of Health (US)
- Department of Medicine, University of Washington, Seattle, WA 98195, USA.
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Walsh, Tom
- McClellan, Jon M.
- McCarthy, Shane E.
- Addington, Anjené M.
- ORCID
- Walsh, Tom
- McClellan, Jon M.
- Addington, Anjené M.
- Pierce, Sarah B.
- Nord, Alex S.
- Malhotra, Dheeraj
- Bhandari, Abhishek
- Lakshmi, B.
- Findling, Robert L.
- Sikich, Linmarie
- Merriman, Barry
- Eckstrand, Kristen
- Gochman, Peter
- Davis, Sean
- Eichler, Evan E.
- Meltzer, Paul S.
- Singleton, Andrew B.
- Lee, Ming K.
- King, Mary-Claire
- Sebat, Jonathan
- Venue
- Science
- Published
- 2008-04-25
- Volume
- 320
- Issue
- 5875
- Pages
- 539-543
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2161641617
- Cited by
- 1,800
- References
- 42
- Citations by year
- 2026: 6 · 2025: 21 · 2024: 43 · 2023: 28 · 2022: 42 · 2021: 49 · 2020: 49 · 2019: 60 · 2018: 60 · 2017: 67 · 2016: 70 · 2015: 99 · 2014: 108 · 2013: 127 · 2012: 177
- FWCI
- 150.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute of Mental Health (MH061355, MH061464, MH061528, U01MH061355, U01MH061528, U01MH061464)
- National Institute of Neurological Disorders and Stroke (U24NS052108, NS052108)
- National Center for Research Resources (RR025014, RR-000046, UL1RR025014, M01RR000046)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD043569, R01HD043569)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- schizophrenia, structural variants, microdeletion, microduplication, brain development, neuregulin signaling, glutamate signaling, childhood schizophrenia, genetic association, copy number variation
- MeSH terms
- Adolescent, Adult, Amino Acid Sequence, Brain, Child, Female, Humans, Male, Molecular Sequence Data, Mutation, Neurons, Schizophrenia, Signal Transduction, Genome, Human, Case-Control Studies, Gene Deletion, Age of Onset, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis, Gene Duplication, Polymorphism, Single Nucleotide, Excitatory Amino Acid Transporter 1, ErbB Receptors, Receptor, ErbB-4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.